SuperNus Pharma Raises $35 Million

Supernus Pharmaceuticals Inc., a Rockville, Md.-based developer of CNS products, has raised around $35 million in its second non-dilutive financing round. Last April, it had announced a $75 million transaction secured by royalties generated from partnered products using Supernus technologies. The company in 2006 raised $45 million in venture capital from firms like Abingworth Management, New Enterprise Associates and OrbiMed Advisors.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget